Home

Edward Miller

CIK 1619252 · General Counsel · last filed 2025-02-24

Edward Miller is a General Counsel who has filed 62 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $1.1K of ALVR on Feb 24, 2025. Across all open-market trades the lifetime net is −$296.7K, making them a net seller over the disclosed history. 9 SEC filings were submitted jointly with ALEXION PHARMACEUTICALS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

62

Lifetime Open-Market Net

-$296.7K

Filer Profile

Reported Address
C/O ALEXION PHARMACEUTICALS, INC
352 KNOTTER DRIVE
CHESHIRE, CT 06410
Related Filers
ALEXION PHARMACEUTICALS, INC. — 9 joint filings, latest 2017-03-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Kalaris Therapeutics, Inc. (ALVR) Delisted General Counsel 21,575 $9.81 $211.7K -$296.7K 32 2025-02-24

Recent Filings

62 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-02-24 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −106 -$1.1K EDGAR
2025-02-24 KLRS Notice (144) −289 -$1.1K EDGAR
2025-01-27 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −52 -$494 EDGAR
2025-01-24 KLRS Notice (144) −52 -$495 EDGAR
2025-01-13 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −409 -$180 EDGAR
2025-01-10 KLRS Notice (144) −409 -$180 EDGAR
2024-12-11 Kalaris Therapeutics, Inc. (ALVR) Delisted Gift (G) — $0 EDGAR
2024-11-20 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −432 -$237 EDGAR
2024-11-19 KLRS Notice (144) −432 -$235 EDGAR
2024-11-06 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −2,272 -$2.0K EDGAR
Showing 1–10 of 62
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.